These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
24. Differential effects of aging on NADPH-diaphorase and VIP neurons in cerebral cortex of rats. Huh Y; Kim C; Cho J; Lee W; Kim J; Ahn H Neuroreport; 1997 Sep; 8(13):2991-4. PubMed ID: 9376544 [TBL] [Abstract][Full Text] [Related]
25. Vasoactive intestinal polypeptide (VIP) inhibits potassium-induced release of cholecystokinin (CCK) from rat caudato-putamen but not from cerebral cortex. Allard LR; Beinfeld MC Neuropeptides; 1986 Oct; 8(3):287-93. PubMed ID: 3785588 [TBL] [Abstract][Full Text] [Related]
26. Galanin blocks the slow cholinergic EPSP in CA1 pyramidal neurons from ventral hippocampus. Dutar P; Lamour Y; Nicoll RA Eur J Pharmacol; 1989 May; 164(2):355-60. PubMed ID: 2474449 [TBL] [Abstract][Full Text] [Related]
27. Vasoactive intestinal polypeptide acts synergistically with norepinephrine to depress spontaneous discharge rate in cerebral cortical neurons. Ferron A; Siggins GR; Bloom FE Proc Natl Acad Sci U S A; 1985 Dec; 82(24):8810-2. PubMed ID: 3866254 [TBL] [Abstract][Full Text] [Related]
29. Electrical and mechanical effects of vasoactive intestinal peptide and pituitary adenylate cyclase-activating peptide in the rat colon involve different mechanisms. Plujà L; Fernández E; Jiménez M Eur J Pharmacol; 2000 Feb; 389(2-3):217-24. PubMed ID: 10688987 [TBL] [Abstract][Full Text] [Related]
30. Effects of low concentrations of 4-aminopyridine on CA1 pyramidal cells of the hippocampus. Perreault P; Avoli M J Neurophysiol; 1989 May; 61(5):953-70. PubMed ID: 2566657 [TBL] [Abstract][Full Text] [Related]
31. Pre- and postsynaptic GABAB receptors of rat neocortical neurons differ in their pharmacological properties. Deisz RA; Billard JM; Zieglgänsberger W Neurosci Lett; 1993 May; 154(1-2):209-12. PubMed ID: 8395667 [TBL] [Abstract][Full Text] [Related]
32. Ultrastructural evidence for combined action of noradrenaline and vasoactive intestinal polypeptide upon neurons, astrocytes, and blood vessels of the rat cerebral cortex. Paspalas CD; Papadopoulos GC Brain Res Bull; 1998; 45(3):247-59. PubMed ID: 9510417 [TBL] [Abstract][Full Text] [Related]
33. Maxadilan specifically interacts with PAC1 receptor, which is a dominant form of PACAP/VIP family receptors in cultured rat cortical neurons. Tatsuno I; Uchida D; Tanaka T; Saeki N; Hirai A; Saito Y; Moro O; Tajima M Brain Res; 2001 Jan; 889(1-2):138-48. PubMed ID: 11166697 [TBL] [Abstract][Full Text] [Related]
34. Acamprosate (calciumacetylhomotaurinate) decreases postsynaptic potentials in the rat neocortex: possible involvement of excitatory amino acid receptors. Zeise ML; Kasparov S; Capogna M; Zieglgänsberger W Eur J Pharmacol; 1993 Jan; 231(1):47-52. PubMed ID: 8444281 [TBL] [Abstract][Full Text] [Related]
35. Co-localization of vasoactive intestinal polypeptide, gamma-aminobutyric acid and choline acetyltransferase in neocortical interneurons of the adult rat. Bayraktar T; Staiger JF; Acsady L; Cozzari C; Freund TF; Zilles K Brain Res; 1997 May; 757(2):209-17. PubMed ID: 9200749 [TBL] [Abstract][Full Text] [Related]
37. Repetitive stimulation induced potentiation of excitatory transmission in the rat dorsal horn: an in vitro study. Jeftinija S; Urban L J Neurophysiol; 1994 Jan; 71(1):216-28. PubMed ID: 7908954 [TBL] [Abstract][Full Text] [Related]
38. Depolarization-dependent actions of dihydropyridines on synaptic transmission in the in vitro rat hippocampus. O'Regan MH; Kocsis JD; Waxman SG Brain Res; 1990 Sep; 527(2):181-91. PubMed ID: 1701335 [TBL] [Abstract][Full Text] [Related]
40. Effects of trifluoperazine on synaptically evoked potentials and membrane properties of CA1 pyramidal neurons of rat hippocampus in situ and in vitro. Agopyan N; Krnjević K Synapse; 1993 Jan; 13(1):10-9. PubMed ID: 7678946 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]